Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Nantes University Hospital
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
RRMS Patients with an EDSS score ranging between 0 and 5.5, who initiated either DMF or Teriflunomide before 1/01/2016 and with an available MRI scan and EDSS assessment respectively within 12 and 6 months before treatment initiation Patients who had consent to OFSEP registry Naive patient or treated with prior first line treatment : interferon, glatiramer acetate
You may not be if
Patient with progressive multiple sclerosis
Patients with prior second line Patient with no MRI or EDSS score within the year before DMF or Teriflunomide initiation.
Clareo Health | Comparison of Oral Molecules Preventing Relapses in Multiple Sclerosis
